Items where Author is "Athari, S. S."
![]() | Up a level |
(2025) Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. pp. 36-51. ISSN 14733099 (ISSN)
(2024) Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet. pp. 1199-1226. ISSN 01406736 (ISSN)
(2024) Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020. Eye. pp. 2070-2082. ISSN 0950-222X
(2024) Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020. Eye. pp. 2156-2172. ISSN 0950-222X
(2024) The burden of neurological conditions in north Africa and the Middle East, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet Global Health. E960-E982. ISSN 2214-109X
(2023) Burden of breast cancer and attributable risk factors in the North Africa and Middle East region, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Frontiers in Oncology. ISSN 2234943X (ISSN)
(2023) Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019. Eclinicalmedicine. p. 22.
(2023) Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026. Lancet Global Health. E385-E413. ISSN 2214-109X
(2023) The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories A Systematic Analysis for the Global Burden of Disease Study 2019. Jama Oncology. pp. 1401-1416. ISSN 2374-2437
(2023) Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Allergy: European Journal of Allergy and Clinical Immunology. pp. 2232-2254. ISSN 01054538 (ISSN)
(2023) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 203-234. ISSN 0140-6736
(2023) Global, regional, and national burden of low back pain, 1990-2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatology. E316-E329. ISSN 2665-9913
(2023) Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurology. pp. 685-711. ISSN 1474-4422
(2023) Global, regional, and national burden of spinal cord injury, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurology. pp. 1026-1047. ISSN 1474-4422
(2023) Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. Eclinicalmedicine. p. 23.
(2023) Global, regional, and national mortality due to unintentional carbon monoxide poisoning, 2000-2021: results from the Global Burden of Disease Study 2021. Lancet Public Health. E839-E849. ISSN 2468-2667
(2023) Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019. Frontiers in Public Health. ISSN 22962565 (ISSN)
(2023) Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet Haematology. e713-e734. ISSN 2352-3026
(2023) Trends of national and sub-national burden attributed to kidney dysfunction risk factor in Iran: 1990-2019. Frontiers in Endocrinology. ISSN 16642392 (ISSN)
(2023) The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet. pp. 313-335. ISSN 0140-6736
(2022) Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019. Lancet Public Health. E657-E669. ISSN 2468-2667
(2022) Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019. Lancet Infectious Diseases. pp. 1626-1647. ISSN 1473-3099
(2022) Burden of thyroid cancer in North Africa and Middle East 1990–2019. Frontiers in Oncology. ISSN 2234943X (ISSN)
(2022) Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. pp. 2221-2248. ISSN 0140-6736
(2022) Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterology & Hepatology. pp. 627-647.
(2022) Injury burden in individuals aged 50 years or older in the Eastern Mediterranean region, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet Healthy Longevity. e253-e262. ISSN 26667568 (ISSN)
(2022) National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019. Scientific Reports. ISSN 20452322 (ISSN)
(2022) National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019. SCIENTIFIC REPORTS. ISSN 20452322 (ISSN)
(2022) Neonate, Infant, and Child Mortality in North Africa and Middle East by Cause: An Analysis for the Global Burden of Disease Study 2019. Archives of Iranian Medicine. pp. 767-778. ISSN 10292977 (ISSN)
(2022) Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. The Lancet. pp. 185-235. ISSN 01406736 (ISSN)
(2022) Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. LANCET. pp. 185-235. ISSN 0140-6736 1474-547X J9 - LANCET
(2022) The burden of prostate cancer in North Africa and Middle East, 1990–2019: Findings from the global burden of disease study. Frontiers in Oncology. ISSN 2234943X (ISSN)
(2022) The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Healthy Longevity. E754-E776. ISSN 2666-7568
(2021) Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018. Nature Medicine. pp. 1761-1782. ISSN 10788956 (ISSN)
(2021) Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. LANCET. pp. 870-905. ISSN 0140-6736 1474-547X J9 - LANCET
(2021) Safety assessment of genetically modified rice expressing Cry1Ab protein in Sprague-Dawley rats. Scientific Reports. ISSN 2045-2322
(2020) Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000-17. Lancet Global Health. E1162-E1185. ISSN 2214-109X
(2020) Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17. Lancet Global Health. pp. 1038-1060. ISSN 2214-109X
(2020) Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. pp. 1250-1284. ISSN 0140-6736